ID

26121

Descripción

Study ID: 111029 Clinical Study ID: 111029 Study Title: Double-blind, randomized study to evaluate the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 6 month schedule in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289757 https://clinicaltrials.gov/ct2/show/NCT00289757 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A Documentation part: Serious Adverse Event

Link

https://clinicaltrials.gov/ct2/show/NCT00289757

Palabras clave

Versiones (1)
  1. 9/10/17 9/10/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

9 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine Serious Adverse Event 111029

Inglés

Serious Adverse Event Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 111029

1 formularios  
Serious Adverse Event
Descripción

Serious Adverse Event

Alias
UMLS CUI-1
C1519255
UMLS CUI-2
C0170300
Serious Adverse Event
Descripción

Serious Adverse Event

Tipo de datos

integer

Alias
UMLS CUI [1]
C1519255
Initials
Descripción

Initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Date of birth
Descripción

Date of birth

Tipo de datos

date

Alias
UMLS CUI [1]
C0421451
Gender
Descripción

Gender

Tipo de datos

text

Alias
UMLS CUI [1]
C0079399
Serious adverse events: Diagnosis only (if known) or signs / symptoms
Descripción

Diagnosis Serious adverse events

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0011900
Specify criteria for considering this as a Serious Adverse Event.
Descripción

Serious Adverse Event

Tipo de datos

integer

Alias
UMLS CUI [1]
C1519255
Autopsy
Descripción

If "Result in death"=Yes, please specify Send autopsy report when available

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004398
UMLS CUI [1,2]
C1519255
Admission date
Descripción

If "Requires in-patient hospitalization"=Yes, please specify

Tipo de datos

date

Alias
UMLS CUI [1]
C1302393
UMLS CUI [2]
C1519255
Discharge date
Descripción

If "Requires in-patient hospitalization"=Yes, please specify

Tipo de datos

date

Alias
UMLS CUI [1]
C2361123
UMLS CUI [2]
C1519255
Discharge date
Descripción

If "Prolongation of existing hospitalization"=Yes, please specify

Tipo de datos

date

Alias
UMLS CUI [1]
C2361123
UMLS CUI [2]
C1519255
Medically important event
Descripción

If "Medically important event"=Yes, please specify

Tipo de datos

text

Alias
UMLS CUI [1]
C2826307
Other events (not SAE) to be reported in the same way
Descripción

=Cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C2826307
Start Date
Descripción

Start Date

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0808070
Time started
Descripción

Time started

Tipo de datos

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1519255
End Date
Descripción

(If ongoing please leave blank)

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0806020
Time stopped
Descripción

(If ongoing please leave blank)

Tipo de datos

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1519255
Maximum Intensity
Descripción

Maximum Intensity

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1710056
UMLS CUI [1,2]
C1519255
In your opinion, did the vaccine possibly contribute to the SAE :
Descripción

Relationship to vaccine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0170300
UMLS CUI [1,3]
C0085978
UMLS CUI [1,4]
C1519255
Other possible contributors:
Descripción

Cause of SAE

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C1519255
Please specify cause of SAE if Other
Descripción

Cause of SAE

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C1519255
Outcome
Descripción

Outcome

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1705586
UMLS CUI [1,2]
C1519255
Action taken with respect to study vaccine
Descripción

Action taken with respect to study vaccine

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1704758
UMLS CUI [1,2]
C0170300
UMLS CUI [1,3]
C1519255
Events after further vaccination
Descripción

Events after further vaccination

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C1519255
Was subject withdrawn due to this specific SAE ?
Descripción

Withdrawal

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1519255
Relevant intercurrent illness & medical history that could have contributed to this SAE
Descripción

Relevant Medical Conditions

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0262926
UMLS CUI [2]
C1519255
Condition still present?
Descripción

Condition still present

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2745955
UMLS CUI [1,2]
C0012634
UMLS CUI [2]
C1519255
Description
Descripción

(provide a brief narrative description of the SAE including relevant diagnostic findings, lab data & evolution of the events etc…)

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1519255
Investigator Signature
Descripción

Investigator Signature

Tipo de datos

text

Alias
UMLS CUI [1]
C2346576
Study vaccine information
Descripción

Study vaccine information

Alias
UMLS CUI-1
C0042210
UMLS CUI-2
C0170300
UMLS CUI-3
C0304229
Vaccine
Descripción

Vaccine

Tipo de datos

text

Alias
UMLS CUI [1]
C0042210
Dose No
Descripción

Dose No

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C3174092
UMLS CUI [1,2]
C0449788
UMLS CUI [2]
C0042210
Lot No
Descripción

Lot Number

Tipo de datos

integer

Alias
UMLS CUI [1]
C2826710
UMLS CUI [2]
C0042210
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0042210
Site
Descripción

Site

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Date
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0042210
UMLS CUI [1,2]
C0011008
Concomitant medication / vaccination that could have contributed to this SAE
Descripción

Concomitant medication / vaccination that could have contributed to this SAE

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0042210
Relevant Concomitant Medications: Drug/vaccine name
Descripción

Concomitant medication / vaccination that could have contributed to this SAE

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C2360065
UMLS CUI [2]
C1519255
Relevant Concomitant Medications: Dosage
Descripción

Dosage

Tipo de datos

float

Alias
UMLS CUI [1,1]
C3174092
UMLS CUI [1,2]
C2347852
UMLS CUI [2]
C1519255
Relevant Concomitant Medications: Frequency
Descripción

Frequency

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3476109
UMLS CUI [1,2]
C2347852
UMLS CUI [2]
C1519255
Relevant Concomitant Medications: Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C2347852
UMLS CUI [2]
C1519255
Relevant Concomitant Medications: Start Date
Descripción

Start Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C2347852
UMLS CUI [2]
C1519255
Relevant Concomitant Medications: Stop date
Descripción

Stop date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C2347852
UMLS CUI [2]
C1519255
Drug(s) used to treat this SAE
Descripción

Drug(s) used to treat this SAE

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0087111
UMLS CUI-3
C1519255
Drug name
Descripción

Drug name

Tipo de datos

text

Alias
UMLS CUI [1]
C2360065
Dosage
Descripción

Dosage

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0013227
Frequency
Descripción

Frequency

Tipo de datos

text

Alias
UMLS CUI [1]
C3476109
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Start Date
Descripción

Start Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
End date
Descripción

End date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Surgical treatment for this SAE, please specify
Descripción

Surgical treatment

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C1519255
Volver a la parte superior de la página

Similar models

Serious Adverse Event Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 111029

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Serious Adverse Event
C1519255 (UMLS CUI-1)
C0170300 (UMLS CUI-2)
Item
Serious Adverse Event
integer
C1519255 (UMLS CUI [1])
Serious Adverse Event
Code List
Serious Adverse Event
CL Item
Initial report (1)
CL Item
Additional info (2)
Initials
Item
Initials
text
C2986440 (UMLS CUI [1])
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Gender
text
C0079399 (UMLS CUI [1])
Gender
Code List
Gender
CL Item
Male (M)
CL Item
Female (F)
Diagnosis Serious adverse events
Item
Serious adverse events: Diagnosis only (if known) or signs / symptoms
text
C1519255 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
Item
Specify criteria for considering this as a Serious Adverse Event.
integer
C1519255 (UMLS CUI [1])
Serious Adverse Event
Code List
Specify criteria for considering this as a Serious Adverse Event.
CL Item
Result in death (1)
CL Item
Life threatening (2)
CL Item
Result in persistent or significant disability/incapacity (3)
CL Item
Requires in-patient hospitalization. (4)
CL Item
Prolongation of existing hospitalization (5)
CL Item
Congenital anomaly / birth defect in the offspring of a study subject. (6)
CL Item
“Medically important” event (7)
autopsy
Item
Autopsy
boolean
C0004398 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Admission date
Item
Admission date
date
C1302393 (UMLS CUI [1])
C1519255 (UMLS CUI [2])
Discharge date
Item
Discharge date
date
C2361123 (UMLS CUI [1])
C1519255 (UMLS CUI [2])
discharge date
Item
Discharge date
date
C2361123 (UMLS CUI [1])
C1519255 (UMLS CUI [2])
Medically important event
Item
Medically important event
text
C2826307 (UMLS CUI [1])
Other events
Item
Other events (not SAE) to be reported in the same way
boolean
C0006826 (UMLS CUI [1])
C2826307 (UMLS CUI [2])
Start Date
Item
Start Date
text
C1519255 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Time started
Item
Time started
time
C0040223 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
End Date
Item
End Date
date
C1519255 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Time stopped
Item
Time stopped
time
C0040223 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item
Maximum Intensity
integer
C1710056 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Maximum Intensity
Code List
Maximum Intensity
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
Relationship to vaccine
Item
In your opinion, did the vaccine possibly contribute to the SAE :
boolean
C0304229 (UMLS CUI [1,1])
C0170300 (UMLS CUI [1,2])
C0085978 (UMLS CUI [1,3])
C1519255 (UMLS CUI [1,4])
Item
Other possible contributors:
integer
C0085978 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Cause of SAE
Code List
Other possible contributors:
CL Item
Medical history  (1)
CL Item
Other medication (2)
CL Item
Protocol required procedure (3)
CL Item
Other procedure (4)
CL Item
Lack of efficacy (5)
CL Item
Erroneous administration (6)
CL Item
Other (7)
Cause of SAE
Item
Please specify cause of SAE if Other
text
C0085978 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item
Outcome
integer
C1705586 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Outcome
Code List
Outcome
CL Item
Recovered (1)
CL Item
Recovered with sequelae (2)
CL Item
Ongoing (3)
CL Item
Died (4)
Item
Action taken with respect to study vaccine
integer
C1704758 (UMLS CUI [1,1])
C0170300 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Action taken with respect to study vaccine
Code List
Action taken with respect to study vaccine
CL Item
None (1)
CL Item
Vaccination course postponed (2)
CL Item
Vaccination course stopped (3)
Item
Events after further vaccination
integer
C0042196 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Events after further vaccination
Code List
Events after further vaccination
CL Item
Event reappeared (1)
CL Item
Event did not reappear (2)
CL Item
Unknown at this time (3)
CL Item
Not applicable (4)
Withdrawal
Item
Was subject withdrawn due to this specific SAE ?
boolean
C2349954 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Relevant Medical Conditions
Item
Relevant intercurrent illness & medical history that could have contributed to this SAE
text
C0012634 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Condition still present
Item
Condition still present?
boolean
C2745955 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Description
Item
Description
text
C0678257 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Investigator Signature
Item
Investigator Signature
text
C2346576 (UMLS CUI [1])
Item Group
Study vaccine information
C0042210 (UMLS CUI-1)
C0170300 (UMLS CUI-2)
C0304229 (UMLS CUI-3)
Vaccine
Item
Vaccine
text
C0042210 (UMLS CUI [1])
Dose No
Item
Dose No
integer
C3174092 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
C0042210 (UMLS CUI [2])
Lot Number
Item
Lot No
integer
C2826710 (UMLS CUI [1])
C0042210 (UMLS CUI [2])
Route
Item
Route
text
C0013153 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Site
Item
Site
text
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Date
Item
Date
date
C0042210 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Concomitant medication / vaccination that could have contributed to this SAE
C2347852 (UMLS CUI-1)
C0042210 (UMLS CUI-2)
Drug or vaccine name
Item
Relevant Concomitant Medications: Drug/vaccine name
text
C2347852 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Dosage
Item
Relevant Concomitant Medications: Dosage
float
C3174092 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Frequency
Item
Relevant Concomitant Medications: Frequency
text
C3476109 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Route
Item
Relevant Concomitant Medications: Route
text
C0013153 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Start Date
Item
Relevant Concomitant Medications: Start Date
date
C0808070 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Stop date
Item
Relevant Concomitant Medications: Stop date
date
C0806020 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Item Group
Drug(s) used to treat this SAE
C0013227 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
Drug name
Item
Drug name
text
C2360065 (UMLS CUI [1])
Dosage
Item
Dosage
text
C0178602 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
End date
Item
End date
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Surgical treatment
Item
Surgical treatment for this SAE, please specify
text
C0543467 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial